News

November 28, 2006

EarlySense completed $4.8 Million Series B Investment Round

Ramat Gan , ISRAEL . - EarlySense, an Israeli company developing a monitoring system for the improved care of Asthma, COPD and Congestive Heart Failure patients, announced today on the closing of a $4.8 million second round of financing. This round was led by the Israeli-based Etgar Challenge Fund joined by Docor International Management Ltd., Bridge Investment Fund and several other Israeli and European VCs and private investors. The company raised about $1.25 million U.S. Dollars in two previous rounds: the seed round in 2004 from private investors and a first round from the Challenge Fund in 2005.

About EarlySense:
EarlySense developed a monitoring system focused on improving the care of Asthma, COPD and Congestive Heart Failure patients. The system operates without any contact with the patient's body and without the need for patient compliance. It analyzes breathing and heart rate patterns during sleep and identifies early warning signs of the deterioration of these diseases. When deterioration is identified - normally one to two nights before the patient is aware - the system alerts and enables therapy to be given immediately - at a point when the full attack can often be stopped and hospitalization prevented. In late 2006, the U.S. Patent Office granted the company a wide ranging patent which covers the system's application for several chronic conditions.

More News